Schering/IBA set up UK PET (positron emission tomography) imaging radiotracer company:
This article was originally published in Clinica
Schering AG's UK business, Schering Health Care, has teamed up with IBA of Belgium to form a new UK company for the supply of a positron emission tomography (PET) imaging radiotracer. UK Radiopharma will be the country's first commercially licensed supplier of F-18 fluodeoxyglucose (FDG), which it will sell as Flucis. Market launch is expected by 2005. Schering AG and IBA (which already sells FDG in the US) plan eventually to create a European network of FDG production sites. FDG is the most commonly used radioactive tracer used in PET imaging for cancer diagnosis and treatment monitoring.